These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1908617)

  • 1. [Quantitative study of rat diabetic cataract, by the relaxation times of nuclear magnetic resonance].
    Mori K; Terubayashi H; Akagi Y; Okamoto S; Tsutsumi M; Ikebe H; Yoshizaki K; Nishikawa H
    Nippon Ganka Gakkai Zasshi; 1991 Apr; 95(4):336-42. PubMed ID: 1908617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance imaging study on rat sugar cataract].
    Mori K
    Nippon Ganka Gakkai Zasshi; 1993 Oct; 97(10):1157-64. PubMed ID: 8256667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventional and therapeutic effects of aldose reductase inhibitor FR74366 on rat galactose cataract].
    Tsuji T; Matsumoto Y; Mori K; Ikebe H; Terubayashi H; Akagi Y; Tanimoto T
    Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):120-7. PubMed ID: 2114732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H-NMR analysis of nerve edema in the streptozotocin-induced diabetic rat.
    Suzuki E; Yasuda K; Yasuda K; Miyazaki S; Takeda N; Inouye H; Omawari N; Miura K
    J Lab Clin Med; 1994 Nov; 124(5):627-37. PubMed ID: 7964120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
    J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prefeeding of aldose reductase inhibitor inhibits galactose cataract].
    Tsuji T; Okamoto S; Ikebe H; Terubayashi H; Akagi Y; Tanimoto T
    Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):455-9. PubMed ID: 8317365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J; Kim CS; Sohn E; Lee YM; Kim JS
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
    Gervasi GB; Bartoli C; Catalani R; Farina C; Carpita G; Caccia G; Ammannati P
    Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats.
    Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2008 Jan; 106(1):144-51. PubMed ID: 18187926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1669-73. PubMed ID: 2950739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetic cataract and flavonoids (first results) (author's transl)].
    Leuenberger PM
    Klin Monbl Augenheilkd; 1978 Apr; 172(4):460-2. PubMed ID: 418268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV; Takahashi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition effect of epalrestat on rat lens osmotic expansion].
    Ji LX; Shen N; Li CN; Liu Q; Huan Y; Shen ZF
    Yao Xue Xue Bao; 2009 Oct; 44(10):1107-11. PubMed ID: 20055132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.